Henri A. Termeer - Genzyme
Total Compensation: $14.6 million
Details: Termeer spent part of 2007 convincing investors that, unlike Biogen Idec and MedImmune, Genzyme wasn't a good takeover target. For his efforts, Termeer gained $1.5 million in base salary--a 5 percent increase over 2006--about $2.1 million in bonuses, $10 million in option awards, and $105,773 in other expenses like travel, insurance and 401(k) contributions.
Genzyme on buyouts: Thanks but no thanks
Icahn sells Genzyme stock